Many times through the years, HealthNewsReview.org has criticized the National Press Foundation in Washington, DC, for accepting drug company funding for journalism training. (See articles from June 2009, July 2009, August 2010, September 2010, October 2010, March 2014, March 2015, December 2015, November 2019. I may have missed a few, but you get the picture.) They’re doing it… Read More »
For a worker in the U.S. who benefits from health insurance at the workplace, the annual family premium will average $ 21,342 this year, according to the 2020 Employer Health Benefits Survey from the Kaiser Family Foundation. The first chart illustrates the growth of the premium shares split by employer and employee contributions. Over ten… Read More »
After Pfizer’s Ibrance failed a crucial study in HR-positive, HR-negative postsurgery breast cancer patients, the company clung to hope that it could still show a benefit in a high-risk subset of those patients. But new data have officially snuffed out those hopes. There’s “no saving adjuvant for Ibrance,” SVB Leerink analyst Geoffrey Porges wrote in… Read More »
The technology of hearing aids has come a long way from the horns and trumpets of centuries past. And with more sophisticated devices and a greater understanding of our ears in general, hearing aids have become cleverer and less noticeable. At the forefront of this innovation is the rise of the ITE – or ‘in… Read More »
Health in 2 Point 00 Oct 9, 2020• Today on Health in 2 Point 00, Jess and I gossip about the wild rumor that UnitedHealthcare is acquiring Amwell. On Episode 157, we discuss Lark raising $ 55 million in a Series C along with a deal with Anthem to be their preferred DPP provider, Medicare… Read More »